Revvity | PKI - Market Capitalization


Revvity reported $14.1B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
Bio Techne USD 8.18B 987M Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.32B 36M Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
Intuitive Surgical USD 163.73B 37.04B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Mettler Toledo International USD 25.54B 2.94B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pharma Mar EUR 1.57B 225M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Quidel USD 1.01B 984M Mar/2026
Repligen USD 6.64B 2.58B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Waters USD 29.87B 7.25B Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025